Developer docs
API playgroundTry for free, no card

Search company profiles

Bure Equity AB

Full company profile

uuid00311lu

Namestring
Bure Equity AB
Legal namestring
Bure Equity AB (publ)
Websiteurl
bure.se
Company typeenum
Public
Founded yearint
1992
Descriptiontext

Bure Equity AB is a Swedish investment company (investmentbolag) founded in 1992 from the winding-up of Sweden's wage earner investment funds and listed on Nasdaq Stockholm Large Cap in 1993 under ticker BURE (ISIN SE0000195810). Its operating model is active long-term ownership of a diversified portfolio of professionally managed Nordic and global companies; Bure does not sell products or services to external customers and does not develop proprietary technology at the parent level. The group generates its financial results from changes in the fair value of, and income from, its portfolio holdings rather than top-line operating revenue.

The portfolio comprises 11 main holdings with substantial sector and geography dispersion. The dominant position is Mycronic (53.8% of NAV as of March 31, 2026), a Nasdaq Stockholm Large Cap producer of electronics manufacturing equipment operating in 50+ countries. Other notable holdings include Vitrolife (11.2%, fertility treatment medtech), Allgon (5.5%, industrial radio remote control, 380+ employees in 19 countries, 93.9%-owned), XVIVO Perfusion (5.7%, transplant solutions), Bure Growth (5.1%, wholly-owned growth-stage investor in BioLamina, My Driving Academy Sweden, Nodica Group), Silex Microsystems (5.0%, MEMS foundry, acquired in July 2025), Yubico (3.0%, phishing-resistant MFA hardware sold in 160+ countries), Cavotec (2.9%, maritime/aviation electrification), Atle Investment Management (2.5%, wholly-owned fund management platform, 93% stake), Mentimeter (2.0%, interactive presentation SaaS, co-owned since 2024), and Mercuri International Group (~0.0%, European sales and leadership training, majority-owned since 1998).

Bure's revenue model is the classic investmentbolag construct: it earns dividends, interest, and valuation gains on its stakes rather than product revenue. Pricing is set by the public market via the BURE share price, with a one-share trading lot on Nasdaq Stockholm and approximately 46,227 shareholders (Top 10 hold 57.8%, led by the Tigerschiöld family at ~10.4%). Its go-to-market is the public equity market itself, supported by a traditional IR apparatus (financial reports, IR website, CEO video commentary, press release subscription service). The customer base in operational terms is its portfolio companies, which Bure supports through board representation, capital allocation, and active ownership rather than direct service delivery.

Short descriptiontext

Bure Equity AB is a Swedish investment company (investmentbolag) that actively owns and develops a diversified portfolio of 11 main holdings spanning electronics manufacturing, medtech, industrial automation, cybersecurity, and interactive software, led by its majority stake in Mycronic.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
investment holding company, active ownership, portfolio investment, long-term equity, investment management
NAICS code1 code
  • Miscellaneous Financial Investment Activities523999
SIC code1 code
  • Non-Operating Establishments9995
Product category
Investment Holding Company
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bure Equity AB is a Swedish investment company that actively owns and develops a diversified portfolio of professionally managed companies. The company operates 11 main holdings across electronics manufacturing equipment, medtech and fertility, industrial automation, MEMS foundry services, cybersecurity, connection/electrification systems, interactive presentation software, sales consulting, growth-stage investments, and active fund management. Founded in 1992 from Sweden's wage earner investment funds and listed on Nasdaq Stockholm in 1993, Bure provides capital, active strategic ownership, and administrative services to its portfolio companies.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bure Equity AB is a Swedish investment company (investmentbolag) that actively manages a diversified portfolio of professionally owned companies. Rather than offering a unified software product, Bure operates as an investment holding company with strategic holdings across multiple sectors including technology, healthcare, and industrial services. The portfolio consists of 11 main holdings: Mycronic (production equipment for electronics, 53.8% of net asset value), Vitrolife (fertility treatment products, 11.2%), Allgon (industrial radio remote control, 5.5%), XVIVO Perfusion (transplantation solutions, 5.7%), Silex Microsystems (MEMS foundry services, 5.0%), Yubico (cybersecurity hardware including YubiKey, 3.0%), Cavotec (connection systems, 2.9%), Mentimeter (interactive presentations, 2.0%), Bure Growth (growth company investments, 5.1%), Atle (investment management, 2.5%), and Mercuri International (sales consulting, 0.0%). The company was formed in 1992 from Sweden's wage earner investment funds and listed on Nasdaq Stockholm in 1993.

Product and service12 records
1Bure Equity AB Active Ownership and Portfolio Development
CategoryInvestment Holding / Active Ownership
Description

Long-term capital deployment and active strategic ownership across a diversified portfolio of professionally managed companies; administrative services for companies where Bure owns shares or participations.

2Bure Growth
CategoryGrowth-stage Investment Subsidiary
Description

Wholly-owned subsidiary that invests in growth-stage companies on behalf of the Bure group.

3Atle Investment Management
CategoryInvestment Management
Description

Wholly-owned subsidiary providing active investment management services for financial operations and assets.

4Yubico (YubiKey)
CategoryCybersecurity Hardware (Portfolio Holding)
Description

Hardware security keys delivering phishing-resistant multi-factor authentication for secure access to computers, mobile devices, servers, browsers, and internet accounts.

5Mentimeter
CategoryInteractive Presentation Software (Portfolio Holding)
Description

Interactive presentation platform enabling real-time audience participation via mobile devices during presentations, meetings, and trainings.

6Silex Microsystems (MEMS Foundry Services)
CategoryMEMS Foundry Services (Portfolio Holding)
Description

World-leading pure-play MEMS foundry services producing semiconductors with mechanically movable components for medtech, automotive, automation, and cloud services from its Stockholm facility.

7Allgon Group (Industrial Radio Remote Control)
CategoryIndustrial Radio Remote Control (Portfolio Holding)
Description

Industrial radio remote control systems and solutions marketed through subsidiaries Tele Radio and Åkerströms, serving industrial, construction, and transportation sectors across 19 countries.

8Mycronic (Production Equipment for Electronics Manufacturing)
CategoryElectronics Manufacturing Equipment (Portfolio Holding)
Description

Production equipment for electronics manufacturing, supplying industry leaders in more than 50 countries with high-utilization production solutions; Swedish high-tech company active in electronics industry for over 40 years.

9Vitrolife (Fertility Treatment Products)
CategoryMedtech - Fertility (Portfolio Holding)
Description

Medical technology products and systems for fertility treatment, including development, production, and marketing of assisted reproduction solutions; international medical technology group with approximately 400 employees and facilities in over 10 countries.

10XVIVO Perfusion (Transplant Solutions)
CategoryMedtech - Transplantation (Portfolio Holding)
Description

Clinically optimized solutions and systems for preservation and perfusion of organs, tissues, and cells used in transplantation procedures.

11Cavotec (Connection and Electrification Systems)
CategoryIndustrial Electrification (Portfolio Holding)
Description

Automated connection and electrification systems for ships, aircraft, and mobile equipment, supporting cleaner and more efficient operations across 30 countries.

12Mercuri International (Sales and Leadership Consulting)
CategorySales and Leadership Consulting (Portfolio Holding)
Description

Sales and leadership consulting and training services delivered via organic growth and acquisitions across European markets.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swedish family-controlled investment company with a portfolio focused on listed Nordic equities and real estate. Comparable to Bure in its long-term investment horizon and concentration of holdings in a select group of companies.

TypeDirect peer
Description

Swedish listed investment company with a portfolio of listed Nordic large-caps. Closely comparable structure to Bure, with a similar long-term, value-oriented investment philosophy and active ownership approach.

TypeDirect peer
Description

Swedish listed investment company that partnered with Bure to acquire Silex Microsystems in 2025. Operates with a similar investment approach and is a direct peer in both portfolio style and the Swedish investment company universe.

TypeDirect peer
Description

Swedish listed investment company focused on listed small and mid-cap Swedish equities. Operates with a similar long-term, dividend-oriented approach to Bure, though with a more passive, market-cap-weighted portfolio.

TypeDirect peer
Description

Swedish listed investment company split between wholly-owned industrial operations and a listed equities portfolio. Comparable to Bure in its long-term ownership model and focus on creating value through active engagement.

TypeDirect peer
Description

Sweden's largest listed investment company, holding significant positions in a diversified set of operating companies. Most directly comparable peer to Bure, with the same investmentbolag structure and long-term active ownership philosophy.

TypeBroad incumbent
Description

Large Swedish-listed private equity firm operating private equity, infrastructure, and growth funds globally. Operates broadly in the same Nordic investment ecosystem as Bure but is a fund manager rather than an investment company, making it an incumbent rather than a direct peer.

TypeDirect peer
Description

Swedish listed investment company focused on consumer internet, fintech, and healthcare. Operates with a similar long-term ownership model and holds significant stakes in growth-stage companies, directly comparable to Bure's investment style.

9Ratos
TypeDirect peer
Description

Swedish listed investment company with a portfolio of mainly unlisted mid-market companies. Comparable to Bure in its active ownership and value-creation approach, though with a more control-oriented private equity model.

TypeOthers
Description

Swedish-listed information services provider; included as an adjacent reference for the broader Swedish listed-investment-company ecosystem rather than as a directly comparable peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment9 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bure Equity AB

Investment Holding Companybure.se

Bure Equity AB is a Swedish investment company (investmentbolag) that actively owns and develops a diversified portfolio of 11 main holdings spanning electronics manufacturing, medtech, industrial automation, cybersecurity, and interactive software, led by its majority stake in Mycronic.

What Bure Equity AB does

Bure Equity AB is a Swedish investment company (investmentbolag) founded in 1992 from the winding-up of Sweden's wage earner investment funds and listed on Nasdaq Stockholm Large Cap in 1993 under ticker BURE (ISIN SE0000195810). Its operating model is active long-term ownership of a diversified portfolio of professionally managed Nordic and global companies; Bure does not sell products or services to external customers and does not develop proprietary technology at the parent level. The group generates its financial results from changes in the fair value of, and income from, its portfolio holdings rather than top-line operating revenue.

The portfolio comprises 11 main holdings with substantial sector and geography dispersion. The dominant position is Mycronic (53.8% of NAV as of March 31, 2026), a Nasdaq Stockholm Large Cap producer of electronics manufacturing equipment operating in 50+ countries. Other notable holdings include Vitrolife (11.2%, fertility treatment medtech), Allgon (5.5%, industrial radio remote control, 380+ employees in 19 countries, 93.9%-owned), XVIVO Perfusion (5.7%, transplant solutions), Bure Growth (5.1%, wholly-owned growth-stage investor in BioLamina, My Driving Academy Sweden, Nodica Group), Silex Microsystems (5.0%, MEMS foundry, acquired in July 2025), Yubico (3.0%, phishing-resistant MFA hardware sold in 160+ countries), Cavotec (2.9%, maritime/aviation electrification), Atle Investment Management (2.5%, wholly-owned fund management platform, 93% stake), Mentimeter (2.0%, interactive presentation SaaS, co-owned since 2024), and Mercuri International Group (~0.0%, European sales and leadership training, majority-owned since 1998).

Bure's revenue model is the classic investmentbolag construct: it earns dividends, interest, and valuation gains on its stakes rather than product revenue. Pricing is set by the public market via the BURE share price, with a one-share trading lot on Nasdaq Stockholm and approximately 46,227 shareholders (Top 10 hold 57.8%, led by the Tigerschiöld family at ~10.4%). Its go-to-market is the public equity market itself, supported by a traditional IR apparatus (financial reports, IR website, CEO video commentary, press release subscription service). The customer base in operational terms is its portfolio companies, which Bure supports through board representation, capital allocation, and active ownership rather than direct service delivery.

Bure Equity AB firmographics

Firmographics
Name
Bure Equity AB
Legal name
Bure Equity AB (publ)
Website
https://bure.se
Company type
Public
Founded year
1992
Operating status
Operating
Headcount range
11–50 employees
Short description
Bure Equity AB is a Swedish investment company (investmentbolag) that actively owns and develops a diversified portfolio of 11 main holdings spanning electronics manufacturing, medtech, industrial automation, cybersecurity, and interactive software, led by its majority stake in Mycronic.
Ownership category
akta.pro rank

Where Bure Equity AB is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Bure Equity AB business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Marketing channels3 records

Bure Equity AB product offering

Product offering

Core offering

Bure Equity AB is a Swedish investment company that actively owns and develops a diversified portfolio of professionally managed companies. The company operates 11 main holdings across electronics manufacturing equipment, medtech and fertility, industrial automation, MEMS foundry services, cybersecurity, connection/electrification systems, interactive presentation software, sales consulting, growth-stage investments, and active fund management. Founded in 1992 from Sweden's wage earner investment funds and listed on Nasdaq Stockholm in 1993, Bure provides capital, active strategic ownership, and administrative services to its portfolio companies.

Product overview

Bure Equity AB is a Swedish investment company (investmentbolag) that actively manages a diversified portfolio of professionally owned companies. Rather than offering a unified software product, Bure operates as an investment holding company with strategic holdings across multiple sectors including technology, healthcare, and industrial services. The portfolio consists of 11 main holdings: Mycronic (production equipment for electronics, 53.8% of net asset value), Vitrolife (fertility treatment products, 11.2%), Allgon (industrial radio remote control, 5.5%), XVIVO Perfusion (transplantation solutions, 5.7%), Silex Microsystems (MEMS foundry services, 5.0%), Yubico (cybersecurity hardware including YubiKey, 3.0%), Cavotec (connection systems, 2.9%), Mentimeter (interactive presentations, 2.0%), Bure Growth (growth company investments, 5.1%), Atle (investment management, 2.5%), and Mercuri International (sales consulting, 0.0%). The company was formed in 1992 from Sweden's wage earner investment funds and listed on Nasdaq Stockholm in 1993.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bure Equity AB Active Ownership and Portfolio Development Long-term capital deployment and active strategic ownership across a diversified portfolio of professionally managed companies; administrative services for companies where Bure owns shares or participations.
  • Bure Growth Wholly-owned subsidiary that invests in growth-stage companies on behalf of the Bure group.
  • Atle Investment Management Wholly-owned subsidiary providing active investment management services for financial operations and assets.
  • Yubico (YubiKey) Hardware security keys delivering phishing-resistant multi-factor authentication for secure access to computers, mobile devices, servers, browsers, and internet accounts.
  • Mentimeter Interactive presentation platform enabling real-time audience participation via mobile devices during presentations, meetings, and trainings.
  • Silex Microsystems (MEMS Foundry Services) World-leading pure-play MEMS foundry services producing semiconductors with mechanically movable components for medtech, automotive, automation, and cloud services from its Stockholm facility.
  • Allgon Group (Industrial Radio Remote Control) Industrial radio remote control systems and solutions marketed through subsidiaries Tele Radio and Åkerströms, serving industrial, construction, and transportation sectors across 19 countries.
  • Mycronic (Production Equipment for Electronics Manufacturing) Production equipment for electronics manufacturing, supplying industry leaders in more than 50 countries with high-utilization production solutions; Swedish high-tech company active in electronics industry for over 40 years.
  • Vitrolife (Fertility Treatment Products) Medical technology products and systems for fertility treatment, including development, production, and marketing of assisted reproduction solutions; international medical technology group with approximately 400 employees and facilities in over 10 countries.
  • XVIVO Perfusion (Transplant Solutions) Clinically optimized solutions and systems for preservation and perfusion of organs, tissues, and cells used in transplantation procedures.
  • Cavotec (Connection and Electrification Systems) Automated connection and electrification systems for ships, aircraft, and mobile equipment, supporting cleaner and more efficient operations across 30 countries.
  • Mercuri International (Sales and Leadership Consulting) Sales and leadership consulting and training services delivered via organic growth and acquisitions across European markets.

Companies that use Bure Equity AB

Customer profile

Segments1 record

Ideal customer profiles1 record

Bure Equity AB technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Bure Equity AB partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Bure Equity AB competitors and assessment

Company assessment

Direct peers

  • Lundbergs: Swedish family-controlled investment company with a portfolio focused on listed Nordic equities and real estate. Comparable to Bure in its long-term investment horizon and concentration of holdings in a select group of companies.
  • Industrivärden: Swedish listed investment company with a portfolio of listed Nordic large-caps. Closely comparable structure to Bure, with a similar long-term, value-oriented investment philosophy and active ownership approach.
  • Creades: Swedish listed investment company that partnered with Bure to acquire Silex Microsystems in 2025. Operates with a similar investment approach and is a direct peer in both portfolio style and the Swedish investment company universe.
  • Svolder: Swedish listed investment company focused on listed small and mid-cap Swedish equities. Operates with a similar long-term, dividend-oriented approach to Bure, though with a more passive, market-cap-weighted portfolio.
  • Latour: Swedish listed investment company split between wholly-owned industrial operations and a listed equities portfolio. Comparable to Bure in its long-term ownership model and focus on creating value through active engagement.
  • Investor AB: Sweden's largest listed investment company, holding significant positions in a diversified set of operating companies. Most directly comparable peer to Bure, with the same investmentbolag structure and long-term active ownership philosophy.
  • Kinnevik AB: Swedish listed investment company focused on consumer internet, fintech, and healthcare. Operates with a similar long-term ownership model and holds significant stakes in growth-stage companies, directly comparable to Bure's investment style.
  • Ratos: Swedish listed investment company with a portfolio of mainly unlisted mid-market companies. Comparable to Bure in its active ownership and value-creation approach, though with a more control-oriented private equity model.

Broad incumbents

  • EQT AB: Large Swedish-listed private equity firm operating private equity, infrastructure, and growth funds globally. Operates broadly in the same Nordic investment ecosystem as Bure but is a fund manager rather than an investment company, making it an incumbent rather than a direct peer.

Others

  • Karnov Group: Swedish-listed information services provider; included as an adjacent reference for the broader Swedish listed-investment-company ecosystem rather than as a directly comparable peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Bure Equity AB social profiles

Digital presence

Bure Equity AB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bure Equity AB leadership team

Management profile

Number of profiles

Profiles2 records

Bure Equity AB subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

Bure Equity AB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bure Equity AB M&A and investment

M&A and investment

M&A

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bure Equity AB

What does Bure Equity AB do?

Bure Equity AB is a Swedish investment company that actively owns and develops a diversified portfolio of professionally managed companies. The company operates 11 main holdings across electronics manufacturing equipment, medtech and fertility, industrial automation, MEMS foundry services, cybersecurity, connection/electrification systems, interactive presentation software, sales consulting, growth-stage investments, and active fund management. Founded in 1992 from Sweden's wage earner investment funds and listed on Nasdaq Stockholm in 1993, Bure provides capital, active strategic ownership, and administrative services to its portfolio companies.

Is Bure Equity AB a public or private company?

Bure Equity AB is a public company. It is classified as public and is currently operating.

When was Bure Equity AB founded?

Bure Equity AB was founded in 1992. It employs 11 to 50 people.

Where is Bure Equity AB based?

Bure Equity AB is headquartered in Stockholm, Sweden, in the Europe region.

Who are Bure Equity AB's main competitors?

Direct peers on record are Lundbergs, Industrivärden, Creades, Svolder, Latour, Investor AB, Kinnevik AB and Ratos. EQT AB is listed as a broad incumbent. Karnov Group is listed as an others.

Does Bure Equity AB have an API?

No public API is recorded for Bure Equity AB.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dagens industriBure ökade substansvärdet mer än indexBure's net asset value rose 5% in Q3 2026 to 360 SEK per share. CEO Henrik Blomquist said positive development continued for several portfolio companies. The article is part of a subscription service.Dagens industriMardrömsdag för småspararfavoriten – fem innehav fallerBure fell over 6% on the Stockholm Stock Exchange on Thursday, with all holdings except one dropping, including its largest stake falling over 9%. Analyst Ulf Petersson warned of the EU's massive debt burden.AffarsvarldenSilex utser sin första valberedningSilex Microsystems appointed its first election committee for the annual general meeting on May 25, 2027, in Järfälla. The committee consists of Oskar Hörnell, Hanna Andreen, and Benjamin Yang, representing Bure Equity, Creades, and Sai Microelectronics, respectively.YahooBure Equity (OM:BURE) Builds Momentum, Is It Still 75% Below Fair Value?Bure Equity shares rose 2.4% on the day and 4.4% over the past week, with a 90-day return of 22.5% and a year-to-date return of 34.5%. The stock trades at a P/E of 4.8x, about 75% below a modelled intrinsic value, while the Swedish Capital Markets industry trades at 17.5x.Dagens industriHär skapas familjen Tigerschiölds guldMycronic distributed over a billion kronor to family investment firm Bure, and the owner expressed interest in doubling the company again. The article was published on 9 September 2026.Simply Wall StBure Equity (OM:BURE) Could Be 77% Undervalued After Its Earnings TurnaroundBure Equity reported a sharp turnaround in its second quarter and first half 2026 results, moving from prior period losses to positive revenue and net income. The company's stock price rose to SEK298.6 with a 25.15% year-to-date gain, trading at a P/E of 4.4x which is significantly lower than its Swedish Capital Markets industry average of 18.2x.Simply Wall StBure Equity (OM:BURE) Stock Recasts Its Story With a Sudden Profit ReturnBure Equity reported a sharp return to profitability in Q2 2026, posting net income of approximately SEK7.6 billion and basic earnings per share of SEK102.43, reversing previous losses. This financial turnaround has led to a low P/E ratio of 4.4x, prompting investor debate regarding the sustainability of this profit amidst the company's history of volatility and an upcoming CEO transition.AffarsvarldenBures substansvärde ökar kraftigtInvestment company Bure Equity reported a 41% increase in its net asset value per share to 342.9 SEK for the second quarter, driven by strong performance from portfolio companies Mycronic, Yubico, and Silex. The surge was largely attributed to Silex's stock debut on May 7, which saw a 148% rise from its listing price, significantly boosting Bure's holdings value.Dagens industriBure slog börsen efter ”några motiga kvartal”Bure Investment AB outperformed the stock market in the first half of 2026, driven by strong performance from three portfolio companies that contributed to an increase in net asset value. Outgoing CEO Henrik Blomquist attributed this growth specifically to these key holdings during his final quarter.Dagens industriBure-ägt bolag rusar efter ”regulatorisk milstolpe”Xvivo Perfusion, a company owned by Bure Ventures, has received CE certification for its heart preservation technology, allowing the system to be made available across Europe. This regulatory milestone has driven a significant rise in the company's stock price on the exchange.